Conversations with Giants in Medicine

A conversation with Barbara Kahn
Ushma S. Neill
Ushma S. Neill
Published March 2, 2020
Citation Information: J Clin Invest. 2020;130(3):1053-1054. https://doi.org/10.1172/JCI136339.
View: Text | PDF

A conversation with Barbara Kahn

Abstract

Authors

Ushma S. Neill

×
A conversation with Marc Feldmann, Jacques Miller, and Max Cooper
Marc Feldmann, Ushma S. Neill
Marc Feldmann, Ushma S. Neill
Published January 2, 2020
Citation Information: J Clin Invest. 2020;130(1):1-3. https://doi.org/10.1172/JCI134899.
View: Text | PDF

A conversation with Marc Feldmann, Jacques Miller, and Max Cooper

Abstract

Authors

Marc Feldmann, Ushma S. Neill

×
A conversation with Elaine Fuchs
Ushma S. Neill
Ushma S. Neill
Published November 1, 2019
Citation Information: J Clin Invest. 2019;129(11):4551-4552. https://doi.org/10.1172/JCI133402.
View: Text | PDF

A conversation with Elaine Fuchs

Abstract

Authors

Ushma S. Neill

×
A conversation with Lucy Shapiro
Ushma S. Neill
Ushma S. Neill
Published August 1, 2019
Citation Information: J Clin Invest. 2019;129(8):2981-2982. https://doi.org/10.1172/JCI131492.
View: Text | PDF

A conversation with Lucy Shapiro

Abstract

Authors

Ushma S. Neill

×
A conversation with George Church
Ushma S. Neill
Ushma S. Neill
Published April 1, 2019
Citation Information: J Clin Invest. 2019;129(4):1403-1404. https://doi.org/10.1172/JCI128550.
View: Text | PDF

A conversation with George Church

Abstract

Authors

Ushma S. Neill

×
A conversation with Mary-Claire King
Ushma S. Neill
Ushma S. Neill
Published January 2, 2019
Citation Information: J Clin Invest. 2019;129(1):1-3. https://doi.org/10.1172/JCI126050.
View: Text | PDF

A conversation with Mary-Claire King

Abstract

Authors

Ushma S. Neill

×
A conversation with Carla Shatz
Ushma S. Neill
Ushma S. Neill
Published October 1, 2018
Citation Information: J Clin Invest. 2018;128(10):4193-4194. https://doi.org/10.1172/JCI123942.
View: Text | PDF

A conversation with Carla Shatz

Abstract

Authors

Ushma S. Neill

×
A conversation with Cornelia Bargmann
Ushma S. Neill
Ushma S. Neill
Published July 2, 2018
Citation Information: J Clin Invest. 2018;128(7):2655-2656. https://doi.org/10.1172/JCI122804.
View: Text | PDF

A conversation with Cornelia Bargmann

Abstract

Authors

Ushma S. Neill

×
A conversation with Charles Sawyers
Ushma S. Neill
Ushma S. Neill
Published April 2, 2018
Citation Information: J Clin Invest. 2018;128(4):1203-1204. https://doi.org/10.1172/JCI120979.
View: Text | PDF

A conversation with Charles Sawyers

Abstract

Authors

Ushma S. Neill

×
A conversation with Doug Lowy and John Schiller
Ushma S. Neill
Ushma S. Neill
Published January 2, 2018
Citation Information: J Clin Invest. 2018;128(1):1-3. https://doi.org/10.1172/JCI97861.
View: Text | PDF
Peter Agre
Peter Agre was awarded the 2003 Nobel Prize for the discovery of aquaporins. He is currently the director of the Johns Hopkins Malaria Research Institute.
Published November 3, 2014
Conversations with Giants in Medicine
Twenty-six compelling conversations
Since May 2012, the JCI has aired twenty-six interviews with twenty-eight notable scientists for the series Conversations with Giants in Medicine.
Published October 1, 2014
Conversations with Giants in Medicine
Lasker Giants
For the last five years, the JCI has had the privilege of working with the Albert and Mary Lasker Foundation to write profiles on the prizewinners. Coverage of the 2014 laureates will be featured in the October issue. In addition to the news feature...
Published September 2, 2014
Conversations with Giants in Medicine
Napoleone Ferrara
Napoleone Ferrara, of the University of California, San Diego, is best known for isolating and cloning vascular endothelial growth factor (VEGF). He then built the humanized monoclonal antibody against VEGF that led to the blockbuster drugs Avastin ...
Published August 26, 2014
Conversations with Giants in Medicine
Tony Fauci
Tony Fauci is the Director of the National Institute of Allergy and Infectious Diseases within the NIH. His work on HIV is at the forefront of infectious disease research, and he is the leader of the national discussion of infectious disease pandemi...
Published July 1, 2014
Conversations with Giants in Medicine
P. Roy Vagelos
The biochemist P. Roy Vagelos is best known for leading Merck for 20 years, first as President of research and then later as CEO and Chairman of the Board. In his time at Merck, he revolutionized the way the company approached drug discovery, introd...
Published June 2, 2014
Conversations with Giants in Medicine
Bonnie Bassler
Bonnie Bassler of Princeton University and the Howard Hughes Medical Institute has revolutionized the way that we think about microbiology. She elucidated the chemical language that bacteria use to communicate through a process called quorum sensing...
Published April 1, 2014
Conversations with Giants in Medicine
Don Ganem
After a 15-year focus on the biology of the hepatitis B virus (HBV) family, the modern-day microbe hunter Don Ganem turned his attention to KSHV, the herpes virus that is the cause of the AIDS-related neoplasm Kaposi sarcoma (KS). His lab at UCSF wa...
Published February 3, 2014
Conversations with Giants in Medicine
Marc Feldmann
Sir Marc Feldmann’s research over the last 30 years has focused on the understanding of autoimmune disease, specifically the treatment of rheumatoid arthritis (RA). Sir Marc, now at the Kennedy Institute of Rheumatology at Oxford University, c...
Published January 2, 2014
Conversations with Giants in Medicine
Thomas Südhof
The simple fact that you can understand the words on this page, and that you might remember any of this interview tomorrow, is thanks to the simultaneous and precise coordination of communication between the billions of neurons in your brain and per...
Published December 3, 2013
Conversations with Giants in Medicine
Advertisement